1. Home
  2. HERE vs INO Comparison

HERE vs INO Comparison

Compare HERE & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Here Group Limited American Depositary Shares

HERE

Here Group Limited American Depositary Shares

HOLD

Current Price

$1.53

Market Cap

100.6M

Sector

Real Estate

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.01

Market Cap

118.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HERE
INO
Founded
2019
1979
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.6M
118.9M
IPO Year
2022
1999

Fundamental Metrics

Financial Performance
Metric
HERE
INO
Price
$1.53
$1.01
Analyst Decision
Strong Buy
Buy
Analyst Count
3
3
Target Price
★ $4.60
$3.17
AVG Volume (30 Days)
14.3K
★ 2.5M
Earning Date
12-01-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 54.18
EPS
★ N/A
N/A
Revenue
N/A
★ $42,220,086.00
Revenue This Year
N/A
N/A
Revenue Next Year
$182.30
N/A
P/E Ratio
$2.83
★ N/A
Revenue Growth
N/A
★ 19.37
52 Week Low
$1.50
$0.56
52 Week High
$5.80
$2.72

Technical Indicators

Market Signals
Indicator
HERE
INO
Relative Strength Index (RSI) 28.74 38.34
Support Level $1.50 $0.56
Resistance Level $1.94 $1.24
Average True Range (ATR) 0.05 0.08
MACD -0.00 -0.02
Stochastic Oscillator 20.45 16.13

Price Performance

Historical Comparison
HERE
INO

About HERE Here Group Limited American Depositary Shares

Here Group Ltd is dedicated to creating collectible pop toys that evoke joy and emotional resonance. The group design and compelling storytelling, which provide users with a collecting experience that blends artistic value with emotional warmth, continuously convey a joyful and immersive brand culture. Adhering to the brand philosophy of joy, integrity, wonder, and co-creation, the company is building a vibrant ecosystem connecting creativity and emotion, working hand-in-hand with overall toy enthusiasts to create, share, and transmit dreams.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: